Inventor · disambiguated record
Siegfried H. Reich
Also filed as: REICH SIEGFRIED H · REICH SIEGFRIED HEINZ
48 granted patents·14 pending applications·1,333 citations·filing 1994–2023
99Inventor score
Top patents by PatentIndex Score
62 records- 0198US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0298US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0397US7232912B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2005·Granted Jun 19, 2007·94 cites·2 claims
- 0497US6919461B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2002·Granted Jul 19, 2005·103 cites·8 claims
- 0597US6555539B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2001·Granted Apr 29, 2003·171 cites·26 claims
- 0696US7008953B23, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2004·Granted Mar 7, 2006·97 cites·4 claims
- 0795US9382248B2Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·14 cites·25 claims
- 0894US9669031B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·12 cites·20 claims
- 0991US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 1090US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 1189US9814718B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·5 cites·20 claims
- 1289US5863950AHIV protease inhibitorsAGOURON PHARMA·Filed 1994·Granted Jan 26, 1999·44 cites·141 claims
- 1388US11083727B2Piperidine-substituted Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Aug 10, 2021·2 cites·3 claims
- 1488US10577378B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·6 cites·14 claims
- 1588US9957277B2eIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·6 cites·14 claims
- 1686US6362166B1Antipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 2000·Granted Mar 26, 2002·14 cites·45 claims
- 1786US5827891AHIV protease inhibtorsAGOURON PHARMA·Filed 1995·Granted Oct 27, 1998·36 cites·12 claims
- 1886US5714518AHIV protease inhibitors and methods of making the sameAGOURON PHARMA·Filed 1994·Granted Feb 3, 1998·42 cites·12 claims
- 1985US11130757B2Crystalline forms of MNK inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 2085US6462069B2Compounds, pharmaceutical compositions, and methods for inhibiting protein kinasesAGOURON PHARMA·Filed 2001·Granted Oct 8, 2002·21 cites·12 claims
- 2183US11440917B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·1 cites·19 claims
- 2282US2023295179A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2380US10112955B2Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·2 cites·19 claims
- 2480US6534530B1Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesisAGOURON PHARMA·Filed 2000·Granted Mar 18, 2003·12 cites·28 claims
- 2579US11286268B1EIF4E-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·1 cites·28 claims
- 2678US10793551B2Benzimidazole-indole inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·2 cites·16 claims
- 2778US6720346B2Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferationAGOURON PHARMA·Filed 2002·Granted Apr 13, 2004·14 cites·30 claims
- 2877US5856530AAntipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 1997·Granted Jan 5, 1999·32 cites·29 claims
- 2977US2023071483A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3076US5824688AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Oct 20, 1998·20 cites·15 claims
- 3175US2021338673A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3274US11878015B2Piperidine-substituted Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·9 claims
- 3372US6693199B2Method of making HIV protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Feb 17, 2004·2 cites·23 claims
- 3472US6525215B2HIV protease inhibitorsAGOURON PHARMA·Filed 2001·Granted Feb 25, 2003·2 cites·1 claims
- 3571US6369226B1Substituted benzamide inhibitors of rhinovirus 3C proteaseAGOURON PHARMA·Filed 2000·Granted Apr 9, 2002·5 cites·4 claims
- 3671US5827859AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Oct 27, 1998·14 cites·18 claims
- 3770US11952375B2Crystalline forms of Mnk inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·0 cites·6 claims
- 3870US6953858B2HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisAGOURON PHARMA·Filed 2002·Granted Oct 11, 2005·4 cites·16 claims
- 3966US5827858AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Oct 27, 1998·11 cites·15 claims
- 4066US2019209560A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4163US2018085368A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4263US2023108594A1Eif4e-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4362US11014926B2Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2EFFECTOR THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·0 cites·17 claims
- 4462US5846993AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Dec 8, 1998·9 cites·18 claims
- 4561US6214799B1Antipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 1999·Granted Apr 10, 2001·11 cites·34 claims
- 4661US5952343AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Sep 14, 1999·8 cites·24 claims
- 4758US2006111322A1Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2006·Application pending·0 cites
- 4857US6632825B2Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesisAGOURON PHARMA·Filed 2001·Granted Oct 14, 2003·1 cites·11 claims
- 4957US5859002AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Jan 12, 1999·6 cites·15 claims
- 5057US2025243221A1Covalent modifiers of eif4e inhibiting compoundsEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Siegfried H. Reich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →